Advertisement

Reactions Weekly

, Volume 1781, Issue 1, pp 12–12 | Cite as

Vedolizumab not associated with increase in malignancies

Clinical study
  • 17 Downloads

Reference

  1. Card T, et al. Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post-marketing data. Alimentary Pharmacology and Therapeutics : 20 Nov 2019. Available from: URL: http://doi.org/10.1111/apt.15538

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations